---
title: "Mangoceuticals, Inc. (MGRX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MGRX.US.md"
symbol: "MGRX.US"
name: "Mangoceuticals, Inc."
industry: "药品零售商"
---

# Mangoceuticals, Inc. (MGRX.US)

| Item | Detail |
|------|--------|
| Industry | 药品零售商 |
| Location | 美股市场 |
| Website | [www.mangoceuticals.com](https://www.mangoceuticals.com) |

## Company Profile

Mangoceuticals, Inc. 从事男性健康产品和服务的开发、营销和销售，通过美国的远程医疗平台进行。该公司提供以 Mango 品牌为名的勃起功能障碍产品；以 Grow 品牌为名的脱发产品；以 Mojo 品牌为名的激素平衡和治疗产品；以及以 Slim 品牌为名的减肥产品。它还提供口服睾酮癸酸酯，用于治疗男性低睾酮，并作为睾酮替代疗法的一种形式，品牌为 Prime；并为客户提供访问持牌药房的服务，以便在线履行和分发可能作为远程医疗咨询的一部分开处方的某些药物

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:12.000Z

**Overall: D (0.67)**

**Industry**: Drug Retail

| Metric | Value |
|--------|-------|
| Industry Ranking | 4 / 5 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -38.16% |  |
| Net Profit YoY | -105.12% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.37 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5.80M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 466908.00 |  |


**Multi Score**: D

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -142.69% | E |
| Profit Margin | -4245.33% | E |
| Gross Margin | 60.42% | A |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -38.16% | E |
| Net Profit YoY | -105.12% | E |
| Total Assets YoY | 11.76% | B |
| Net Assets YoY | 17.47% | A |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -2.25% | D |
| OCF YoY | -38.16% | E |

#### Operating Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.03 | E |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 4.87% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Mangoceuticals, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-142.69%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-4245.33%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "60.42%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-38.16%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-105.12%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "11.76%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "17.47%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-2.25%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-38.16%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "E",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.03",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "4.87%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 1药网 (US.YI) | C | D | A | E | E | C |
| 02 | Ridgetech (US.RDGT) | D | C | A | C | C | C |
| 03 | 沃尔格林联合博姿 (US.WBA) | E | C | A | E | D | C |
| 04 | Mangoceuticals (US.MGRX) | E | D | E | A | D | D |
| 05 | 九洲大药房 (US.CJJD) | D | C | A | E | E | D |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.28 | 3/4 | - | - | - |
| PB | 0.37 | 1/4 | 1.22 | 0.95 | 0.73 |
| PS (TTM) | 12.42 | 4/4 | 45.33 | 33.66 | 17.45 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/MGRX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MGRX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MGRX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.